X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (123) 123
humans (121) 121
male (114) 114
urology & nephrology (104) 104
middle aged (69) 69
aged (68) 68
urology (51) 51
benign prostatic hyperplasia (36) 36
prostate cancer (35) 35
analysis (33) 33
cancer (30) 30
erectile dysfunction (30) 30
men (30) 30
prostate (29) 29
metabolic syndrome (28) 28
treatment outcome (27) 27
female (26) 26
prospective studies (26) 26
surgery (26) 26
adult (25) 25
lower urinary tract symptoms (24) 24
oncology (24) 24
prostatectomy (19) 19
animals (18) 18
bladder (18) 18
retrospective studies (18) 18
testosterone (18) 18
bph (17) 17
luts (17) 17
quality of life (17) 17
risk factors (17) 17
aged, 80 and over (16) 16
biopsy (16) 16
prostate - pathology (16) 16
radical prostatectomy (16) 16
hyperplasia (15) 15
inflammation (15) 15
medicine & public health (15) 15
multivariate analysis (15) 15
prognosis (15) 15
prostatic hyperplasia - complications (15) 15
urinary-tract symptoms (15) 15
patients (14) 14
prostatic hyperplasia - pathology (14) 14
care and treatment (13) 13
diagnosis (13) 13
italy (13) 13
medical research (13) 13
obesity (13) 13
prostatic neoplasms - surgery (13) 13
urologic and male genital diseases (13) 13
cohort studies (12) 12
double-blind (12) 12
lower urinary tract symptoms - drug therapy (12) 12
medicine, experimental (12) 12
outcomes (12) 12
quality-of-life (12) 12
efficacy (11) 11
health aspects (11) 11
tadalafil (11) 11
endocrinology & metabolism (10) 10
experience (10) 10
follow-up studies (10) 10
lower urinary-tract (10) 10
research (10) 10
risk (10) 10
risk-factors (10) 10
survival (10) 10
vardenafil (10) 10
vardenafil dihydrochloride (10) 10
androgens (9) 9
benign prostatic enlargement (9) 9
diseases of the genitourinary system. urology (9) 9
immunohistochemistry (9) 9
metabolic syndrome - complications (9) 9
neoplasm staging (9) 9
nephrology (9) 9
prostatic neoplasms - pathology (9) 9
time factors (9) 9
urogenital system (9) 9
bladder cancer (8) 8
cells, cultured (8) 8
clinical trials (8) 8
complications (8) 8
impact (8) 8
impotence (8) 8
kidney neoplasms - surgery (8) 8
logistic models (8) 8
lower urinary tract symptoms - etiology (8) 8
mortality (8) 8
original paper (8) 8
progression (8) 8
prostate-specific antigen - blood (8) 8
prostatectomy - methods (8) 8
radiotherapy (8) 8
surveys and questionnaires (8) 8
tamsulosin (8) 8
carcinoma, renal cell - pathology (7) 7
carcinoma, renal cell - surgery (7) 7
cross-sectional studies (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 02/2008, Volume 205, Issue 2, pp. 479 - 490
Journal Article
STEM CELLS, ISSN 1066-5099, 09/2010, Volume 28, Issue 9, pp. 1674 - 1685
Journal Article
World Journal of Urology, ISSN 0724-4983, 8/2016, Volume 34, Issue 8, pp. 1183 - 1192
Journal Article
Journal Article
Journal of Endocrinology, ISSN 0022-0795, 07/2012, Volume 214, Issue 1, pp. 31 - 43
Journal Article
Journal Article
The Journal of Sexual Medicine, ISSN 1743-6095, 10/2011, Volume 8, Issue 10, pp. 2746 - 2760
In humans, prostate phosphodiesterase type 5 inhibitors (PDE5) expression was prominently localized in the endothelial and smooth muscle cells of the vascular... 
Human Vesicular‐Deferential Artery | Prostate Oxygenation | PDE5 Inhibition | Hypoxyprobe | Prostate oxygenation | PDE5 inhibition | Human vesicular-deferential artery | SYMPTOMS SECONDARY | FUNCTIONAL-ACTIVITY | VAS-DEFERENS | NITRIC-OXIDE SYNTHASE | CHRONIC ISCHEMIA | BLOOD-FLOW | CAVERNOUS NEUROTOMY | IMPROVES ERECTILE FUNCTION | HUMAN DEFERENTIAL ARTERY | Human Vesicular-Deferential Artery | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | Muscle, Smooth, Vascular - metabolism | Humans | Rats, Inbred WKY | Male | Nitroprusside - pharmacology | Oxygen - metabolism | Prostate - metabolism | Urinary Tract - enzymology | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Prostate - drug effects | Urinary Tract - metabolism | Phosphodiesterase 5 Inhibitors - pharmacology | Urinary Bladder - enzymology | Cyclic Nucleotide Phosphodiesterases, Type 5 - metabolism | Real-Time Polymerase Chain Reaction | Muscle, Smooth, Vascular - drug effects | Rats, Inbred SHR | Urinary Bladder - metabolism | Endothelin-1 - metabolism | Rats | Tadalafil | Animals | Urinary Tract - blood supply | Urinary Bladder - blood supply | Muscle, Smooth, Vascular - enzymology | Urinary Tract - drug effects | Carbolines - pharmacology | Immunohistochemistry | Hypertension | Messenger RNA | Sodium nitroferricyanide | Cyanides | Cyclic guanylic acid | Endothelium
Journal Article
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 3/2013, Volume 139, Issue 3, pp. 521 - 528
Journal Article
76.